San Clemente, June 25, 2008 – Metagenics, Inc., a leading developer and manufacturer of science-based medical foods and nutraceuticals sold through healthcare practitioners, said today that its CEO, Jeffrey J. Katke, was a finalist for the Ernst & Young Entrepreneur Of The Year Orange County/Desert Cities, California awards program. Katke was among 23 entrepreneurs selected by an independent judging panel made up of regional business, academic and community leaders. The awards ceremony took place June 11, 2008 in Irvine, California.
“This year’s regional finalists represented the best of the best, and embody the unique spirit of entrepreneurism,” said Kurt Binder, Ernst & Young Entrepreneur Of The Year Program Director for Orange County/Desert Cities. “They positively impact our region in a major way, through jobs, community growth and development and innovation. Ernst & Young is proud to salute them.”
Ernst & Young is a global leader in assurance, tax, transaction and advisory services. For 22 years, The Ernst & Young Entrepreneur Of The Year Award has recognized entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. The first and only truly global award of its kind, it is considered the world’s most prestigious business award for entrepreneurs.
About Metagenics, Inc.
Metagenics is a life sciences company and leading developer and manufacturer of professional grade, science-based medical foods and nutraceuticals sold to healthcare practitioners worldwide. For more than 25 years, Metagenics has been a leader in quality, scientific discovery, and innovation, with multiple proprietary formula patents and more than 300 research-based products to optimize health. The company is headquartered in San Clemente, CA, with manufacturing and research facilities located in Gig Harbor, WA, including the MetaProteomics® Nutrigenomics Research Center and the Functional Medicine Research CenterSM for human clinical research. For more information, please visit www.metagenics.com.